Clinical features and outcomes in children with seronegative autoimmune encephalitis
Developmental Medicine & Child Neurology · 2024-10 · 66 (10) · 1310-1318
DOI: 10.1111/dmcn.15896 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 15.03.2024. Verfasst von Jihan Madani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Encephalitis, Hashimoto Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Biogen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To characterize the presenting features and outcomes in children with seronegative autoimmune encephalitis, and to evaluate whether scores at nadir for the Modified Rankin Scale (mRS) and Clinical Assessment Scale for Autoimmune Encephalitis (CASE) or its paediatric‐specific modification (ped‐CASE) are predictive of outcomes.
Method
This observational study included children younger than 18 years of age with seronegative autoimmune encephalitis. Demographics and clinical data were collected. The mRS and CASE/ped‐CASE scores were used to evaluate disease severity. Descriptive statistics and logistic regression were used for data analysis and to evaluate associations between scale scores and outcomes.
Results
Sixty‐three children were included (39 [62%] females, median age 7 years, interquartile range [IQR] 4 years 1 months–11 years 6 months), with follow‐up available for 56 out of 63 patients (median follow‐up 12.2 months, IQR 13.4–17.8). The most frequent presenting neurological manifestation was encephalopathy (81%). Median CASE/ped‐CASE and mRS scores at nadir were 12.0 (IQR 7.0–17.0) and 1.0 (IQR 0–2.0) respectively. Thirty‐three patients (59%) had persistent neurological deficits at follow‐up. Both scoring systems suggested good functional recovery (mRS score ≤2, 95%; CASE/ped‐CASE score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
- Neurosciences and Mental Health Program, SickKids Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Division of Neurology, Dalhousie University IWK Health Center, Halifax, Nova Scotia, Canada.
- Division of Neurology, McMaster University, Hamilton, Ontario, Canada.
- Division of Pediatric Neurology, Department of Pediatrics, Children's Hospital, London Health Science Center, London, Ontario, Canada.
- Pediatric Neurology, Department of Pediatrics, Saint John Regional Hospital, St. John, New Brunswick, Canada.
ORCID-Profile: Colin Wilbur, E Ann Yeh
Förderung
- Biogen
Zitieren
APA
Madani, J., Yea, C., Mahjoub, A., Brna, P., Jones, K., Longoni, G., Nouri, M. N., Rizk, T., Stewart, W. A., Wilbur, C., & Yeh, E. A. (2024). Clinical features and outcomes in children with seronegative autoimmune encephalitis. Developmental Medicine & Child Neurology, 66(10), 1310-1318. https://doi.org/10.1111/dmcn.15896
Vancouver
Madani J, Yea C, Mahjoub A, Brna P, Jones K, Longoni G, et al. Clinical features and outcomes in children with seronegative autoimmune encephalitis. Developmental Medicine & Child Neurology. 2024;66(10):1310-1318. doi:10.1111/dmcn.15896
BibTeX
@article{Madani2024,
author = {Madani, Jihan and Yea, Carmen and Mahjoub, Areej and Brna, Paula and Jones, Kevin and Longoni, Giulia and Nouri, Maryam Nabavi and Rizk, Tamer and Stewart, Wendy A and Wilbur, Colin and Yeh, E Ann},
title = {Clinical features and outcomes in children with seronegative autoimmune encephalitis},
journal = {Developmental Medicine & Child Neurology},
year = {2024},
volume = {66},
number = {10},
pages = {1310--1318},
doi = {10.1111/dmcn.15896}
}
EUVIMED